UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001184
Receipt number R000001041
Scientific Title Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with operable primary lung cancer.
Date of disclosure of the study information 2008/06/12
Last modified on 2008/12/11 11:05:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with operable primary lung cancer.

Acronym

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with operable primary lung cancer.

Scientific Title

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with operable primary lung cancer.

Scientific Title:Acronym

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with operable primary lung cancer.

Region

Japan


Condition

Condition

primary lung cancer (operable case)

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The feasibility of alpha-GalactosylCeramide-pulsed dendritic cell and natural killer T (NKT) cell immunotherapy in patients with operable lung cancer are examined. The immunological responses and anti-tumor effects are also investigated.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

Immunological response

Key secondary outcomes

Safety, Clinical response


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

In patients, intra-venous injection of alpha-GalactosylCeramide pulsed DCs is performed at 1week before operation. Within 3 months after operation he is re-entried, and alpha-GalactosylCeramide pulsed DCs are performed at 1, 2, 7 and 8 weeks after the re-entry.

Interventions/Control_2

In control group, intra-venous injection of alpha-GalactosylCeramide pulsed DCs is not performed before and after operation.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients between 20 and 80 years of age, with a histologic or cytologic diagnosis of non&#8211;small cell lung cancer for which operation is planned.
2. Clinical stage is IIB or IIIA.
3. Performance status of 0, 1, or 2
4. Normal or near normal renal, hepatic, and hematopoietic function
5. NKT cells are detected at least 10 cells in 1 mL of peripheral blood.

Key exclusion criteria

1. Patients who have been treated with surgery or chemotherapy or radiotherapy received for at least 4 weeks before enrollment.
2. Histology is large cell neuroendocrine carcinoma.


3. The exclusion criteria were a positive response to HIV, hepatitis C virus, or human T-cell lymphotrophic virus antibodies; positive for hepatitis B antigen; the presence of active inflammatory disease or active autoimmune disease; a history of hepatitis; pregnancy or lactation; concurrent corticosteroid therapy; and evidence for another active malignant neoplasm. The histologic type, tumor-node-metastasis classification, and the antitumor effect of treatment were classified according to the general rules for clinical and pathologic recording of lung cancer as described by the Japan Lung Cancer Society.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ichiro Yoshino

Organization

Graduate School of Medicine, Chiba University

Division name

Department of Thoracic Surgery

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Graduate School of Medicine, Chiba University

Division name

Department of Thoracic Surgery

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

TEL

043-222-7171

Homepage URL


Email



Sponsor or person

Institute

Department of Thoracic Surgery, Graduate School of Medicine, Chiba University

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 06 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2007 Year 11 Month 01 Day

Last follow-up date

2009 Year 04 Month 01 Day

Date of closure to data entry

2009 Year 04 Month 01 Day

Date trial data considered complete

2009 Year 04 Month 01 Day

Date analysis concluded

2009 Year 04 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 06 Month 11 Day

Last modified on

2008 Year 12 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001041


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name